CITADEL ADVISORS LLC

Position in EVGN — Evogene Ltd.

CIK 1423053 MIAMI, FL

Back to EVGN Full portfolio

Position in EVGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$22,231

-$75,409 QoQ

Shares Held

50,526

-43.1% QoQ

Ownership

0.320%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 13 holders

Holding Since

Mar 2021

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in EVGN Over Time

Shares Held

Position Value (USD)

Derivatives in EVGN

reported options exposure · as of Jun 30, 2024

CallValue

$260

CallShares

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,175,465,875 across 436 Biotechnology names. EVGN ranks #413 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ONC	BeOne Medicines Ltd.	1,425,517	$406,229,578
2	BBIO	BridgeBio Pharma, Inc.	3,760,028	$280,046,885
3	INSM	INSMED Inc	2,556,973	$272,624,460
4	MDGL	Madrigal Pharmaceuticals, Inc.	507,233	$272,358,759
5	VRTX	Vertex Pharmaceuticals Inc / Ma	510,430	$253,545,893
6	JAZZ	Jazz Pharmaceuticals plc	1,006,676	$242,578,715
7	MANE	Veradermics, Inc	1,877,775	$230,853,658
8	ROIV	Roivant Sciences Ltd.	5,576,261	$197,343,876

All Filings in EVGN

Export CSV

40 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,231	50,526	-43.1%	Shares	Defined	2026-08-14
2025-12-31	$97,640	88,764	+54.2%	Shares	Defined	2026-02-17
2025-09-30	$65,635	57,575	+169.4%	Shares	Defined	2025-11-14
2025-06-30	$27,352	21,369	+34.5%	Shares	Defined	2025-08-14
2024-12-31	$29,716	15,891	-33.0%	Shares	Defined	2025-02-14
2024-06-30	$260	400	-98.3%	Call	Defined	2024-08-14
2024-06-30	$15,411	23,710	-60.4%	Shares	Defined	2024-08-14
2024-03-31	$17,250	23,000	+2775.0%	Call	Defined	2024-05-15
2024-03-31	$44,933	59,911	+5.6%	Shares	Defined	2024-05-15
2023-12-31	$47,644	56,720	+106.3%	Shares	Defined	2024-02-14
2023-12-31	$1,764	2,100	0.0%	Put	Defined	2024-02-14
2023-09-30	$1,239	2,100	-88.4%	Put	Defined	2023-11-14
2023-09-30	$472	800	-87.1%	Call	Defined	2023-11-14
2023-09-30	$16,217	27,488	+127.2%	Shares	Defined	2023-11-14
2023-06-30	$6,634	6,200	-22.5%	Call	Defined	2023-08-14
2023-06-30	$12,943	12,097	-78.7%	Shares	Defined	2023-08-14
2023-03-31	$5,040	8,000	-3.6%	Call	Defined	2023-05-15
2023-03-31	$35,864	56,927	-32.7%	Shares	Defined	2023-05-15
2023-03-31	$11,403	18,100	-10.8%	Put	Defined	2023-05-15
2022-12-31	$59,169	84,528	-12.6%	Shares	Defined	2023-02-14
2022-12-31	$14,210	20,300	+37.2%	Put	Defined	2023-02-14
2022-12-31	$5,810	8,300	-61.6%	Call	Defined	2023-02-14
2022-09-30	$17,928	21,600	-44.3%	Call	Defined	2022-11-14
2022-09-30	$80,263	96,703	+534.4%	Shares	Defined	2022-11-14
2022-06-30	$29,876	38,800	+193.9%	Call	Defined	2022-08-15
2022-06-30	$11,396	14,800	-72.3%	Put	Defined	2022-08-15
2022-03-31	$19,816	15,244	-84.9%	Shares	Defined	2022-05-16
2022-03-31	$17,160	13,200	-1.5%	Call	Defined	2022-05-16
2022-03-31	$69,420	53,400	-47.5%	Put	Defined	2022-05-16
2021-12-31	$166,788	101,700	+25.2%	Put	Defined	2022-02-14
2021-12-31	$165,138	100,695	+33.6%	Shares	Defined	2022-02-14
2021-09-30	$35,376	13,400	-89.3%	Call	Defined	2021-11-15
2021-09-30	$198,957	75,363	-33.7%	Shares	Defined	2021-11-15
2021-09-30	$214,368	81,200	-45.1%	Put	Defined	2021-11-15
2021-06-30	$505,818	147,900	+2.6%	Put	Defined	2021-08-16
2021-06-30	$426,474	124,700	-2.1%	Call	Defined	2021-08-16
2021-06-30	$388,528	113,605	-25.6%	Shares	Defined	2021-08-16
2021-03-31	$642,096	127,400	—	Call	Defined	2021-05-21
2021-03-31	$769,889	152,756	—	Shares	Defined	2021-05-21
2021-03-31	$726,264	144,100	—	Put	Defined	2021-05-21
No filing history on record for this holder in this stock.